Aim <p>Patients with locally advanced rectal cancer may avoid surgery if they develop a clinical complete response (cCR) to total neoadjuvant therapy (TNT). During surveillance, detection of local regrowth can be challenging. The ability of MRI to predict local regrowth is uncertain, especially when it differs from endoscopic findings. This study evaluates the ability of MRI and endoscopy to predict local regrowth in patients under surveillance for cCR after TNT.</p> Method <p>All rectal cancer patients in our institution from 2006 to 2020 who achieved cCR following TNT, and entered watch and wait (WW), with findings suspicious for local regrowth during surveillance and subsequently underwent surgery were assessed. The main outcomes were the ability of MRI to correctly identify the local regrowths and its correlation with endoscopy and pathology.</p> Results <p>1426 patients were diagnosed with locally advanced rectal cancer. 388 patients achieved cCR after TNT and underwent surveillance. 112 patients developed clinical and/or radiological findings suspicious of local regrowth. Of 99 patients who proceeded to surgery, 12 (12%) had a pathological complete response (pCR). For patients with an abnormal MRI only and normal endoscopy, pCR rate was 4/9 (44%). For patients with an abnormal endoscopy, pCR rates in those with a normal MRI and those with an abnormal MRI were 6/34 (18%) and 2/56 (4%), respectively (χ<sup>2</sup>-test, <i>p</i> = 0.001). Normal endoscopy was significantly associated with higher odds of pCR (OR 8.2, <i>p</i> = 0.012) whereas normal MRI showed a non-significant association (OR 2.11, <i>p</i> = 0.33).</p> Conclusion <p>In rectal cancer patients achieving cCR after TNT, local regrowth without detectable endoscopic findings is rare. When isolated abnormal MRI findings occur, repeat radiologic surveillance prior to deciding on surgery may minimize unnecessary surgical interventions.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

The value of MRI and flexible sigmoidoscopy in detecting tumor regrowth in watch and wait rectal cancer patients undergoing active surveillance after total neoadjuvant therapy

  • Trevor M. Yeung,
  • Roni Y. Rosen,
  • Aron Bercz,
  • Hannah Williams,
  • Dana Omer,
  • Floris S. Verheij,
  • Ramy Behman,
  • Andrea Marcadis,
  • Jinru Shia,
  • Andrea Cercek,
  • Neil H. Segal,
  • Rona Yaeger,
  • Tae-Hyung Kim,
  • Natally Horvat,
  • Marc J. Gollub,
  • J. Joshua Smith,
  • Leonard Saltz,
  • Julio Garcia-Aguilar,
  • Jinru Shia,
  • Andrea Cercek,
  • Neil H. Segal,
  • Natally Horvat,
  • Marc J. Gollub,
  • J. Joshua Smith,
  • Julio Garcia-Aguilar

摘要

Aim

Patients with locally advanced rectal cancer may avoid surgery if they develop a clinical complete response (cCR) to total neoadjuvant therapy (TNT). During surveillance, detection of local regrowth can be challenging. The ability of MRI to predict local regrowth is uncertain, especially when it differs from endoscopic findings. This study evaluates the ability of MRI and endoscopy to predict local regrowth in patients under surveillance for cCR after TNT.

Method

All rectal cancer patients in our institution from 2006 to 2020 who achieved cCR following TNT, and entered watch and wait (WW), with findings suspicious for local regrowth during surveillance and subsequently underwent surgery were assessed. The main outcomes were the ability of MRI to correctly identify the local regrowths and its correlation with endoscopy and pathology.

Results

1426 patients were diagnosed with locally advanced rectal cancer. 388 patients achieved cCR after TNT and underwent surveillance. 112 patients developed clinical and/or radiological findings suspicious of local regrowth. Of 99 patients who proceeded to surgery, 12 (12%) had a pathological complete response (pCR). For patients with an abnormal MRI only and normal endoscopy, pCR rate was 4/9 (44%). For patients with an abnormal endoscopy, pCR rates in those with a normal MRI and those with an abnormal MRI were 6/34 (18%) and 2/56 (4%), respectively (χ2-test, p = 0.001). Normal endoscopy was significantly associated with higher odds of pCR (OR 8.2, p = 0.012) whereas normal MRI showed a non-significant association (OR 2.11, p = 0.33).

Conclusion

In rectal cancer patients achieving cCR after TNT, local regrowth without detectable endoscopic findings is rare. When isolated abnormal MRI findings occur, repeat radiologic surveillance prior to deciding on surgery may minimize unnecessary surgical interventions.